Clinical Trials Directory

Trials / Completed

CompletedNCT00205309

Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients

Respiratory Tract IgA Levels in Critically Ill Intubated Patients

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will examine the impact of acute illness on sequential airway IgA levels in intensive care patients who will require prolonged intubation. Infections are the most common cause of late deaths in non-head injured trauma patients and a frequent cause of morbidity and mortality in hospitalized patients, especially intubated Intensive Care Unit (ICU) patients. Nosocomial pneumonia is the most common of these infections, and its incidence in defined populations of critically injured patients is responsive to route and type of nutrition. This study will focus on the mechanisms of specific immune mucosal defenses in intestinal and extraintestinal sites and link enteral feeding (or lack of it) with maintenance (or deterioration) of respiratory mucosal defenses.

Conditions

Timeline

Start date
2003-01-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2005-09-20
Last updated
2012-10-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00205309. Inclusion in this directory is not an endorsement.

Airway IgA: Respiratory Tract IgA Levels in Critically Ill Intubated Patients (NCT00205309) · Clinical Trials Directory